Posts in October 8, 2026

by Michael Phelan
October 8, 2026

China’s PIONEER Program for NAMs: What It Means for Chinese (and Global) Biotech

The US has set the pace in moving drug development beyond animal testing. The FDA’s 2025 […]
0
read more